Skip to content
10-Q

Quarterly Report

NEUROPATHIX, INC.

0001607062-20-000324

← back to feed
Filed
Nov 12, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · Nov 10, 2020 75.25M sh
Shares Diluted Q3 2020 · Sep 30, 2020 74.26M sh
Shares Diluted Q3 2020 · Sep 30, 2020 74.24M sh
Shares Diluted Q3 2020 · Sep 30, 2019 70.93M sh
Shares Diluted Q3 2020 · Sep 30, 2019 70.22M sh
Capex Q3 2020 · Sep 30, 2020 $0
Capex Q3 2020 · Sep 30, 2019 $41.95K
Short Term Debt Q3 2020 · Sep 30, 2020 $42.09K
Short Term Debt Q3 2020 · Dec 31, 2019 $42.09K
Current Liabilities Q3 2020 · Sep 30, 2020 $2.09M
Current Liabilities Q3 2020 · Dec 31, 2019 $1.33M
Total Liabilities Q3 2020 · Sep 30, 2020 $3.08M
Total Liabilities Q3 2020 · Dec 31, 2019 $1.92M
Current Assets Q3 2020 · Sep 30, 2020 $264.85K
Current Assets Q3 2020 · Dec 31, 2019 $130.86K
Total Assets Q3 2020 · Sep 30, 2020 $345.27K
Total Assets Q3 2020 · Dec 31, 2019 $223.38K
Eps Diluted Q3 2020 · Sep 30, 2020 −$0.01
Eps Diluted Q3 2020 · Sep 30, 2020 −$0.04
Eps Diluted Q3 2020 · Sep 30, 2019 −$0.02
Eps Diluted Q3 2020 · Sep 30, 2019 −$0.04
Eps Basic Q3 2020 · Sep 30, 2020 −$0.01
Eps Basic Q3 2020 · Sep 30, 2020 −$0.04
Eps Basic Q3 2020 · Sep 30, 2019 −$0.02
Eps Basic Q3 2020 · Sep 30, 2019 −$0.04
Revenue Q3 2020 · Sep 30, 2020 $0
Revenue Q3 2020 · Sep 30, 2020 $0
Revenue Q3 2020 · Sep 30, 2019 $23.97K
Revenue Q3 2020 · Sep 30, 2019 $126.03K
Operating Cash Flow Q3 2020 · Sep 30, 2019 −$2M
Cash And Equivalents Q3 2020 · Sep 30, 2019 $120.55K
Cash And Equivalents Q3 2020 · Dec 31, 2018 $307.13K
Stockholders Equity Q3 2020 · Sep 30, 2019 −$962.6K
Stockholders Equity Q3 2020 · Jun 30, 2019 −$296.94K
Stockholders Equity Q3 2020 · Dec 31, 2018 $1.33M
Sga Expense Q3 2020 · Sep 30, 2019 $601.57K
Sga Expense Q3 2020 · Sep 30, 2019 $1.51M
Rd Expense Q3 2020 · Sep 30, 2019 $189.44K
Rd Expense Q3 2020 · Sep 30, 2019 $439.68K
Net Income Q3 2020 · Sep 30, 2019 −$1.09M
Net Income Q3 2020 · Sep 30, 2019 −$2.72M
Operating Income Q3 2020 · Sep 30, 2019 −$767.04K
Operating Income Q3 2020 · Sep 30, 2019 −$1.82M